YTHDF2 and acute myeloid leukemia: Paris et al. found that the mRNA m6A reader YTHDF2 is overexpressed in AML, its decreased the clonogenic potential of AML cells and enhanced hematopoietic stem cells (HSC) activity by targeting to tumor necrosis factor receptor Tnfrsf2, which contributes to the overall integrity of LSC function179.